Cite
APA Citation
Yoo, D., Miranda, P., Piotrowski, M., Ramiterre, E., Kovalenko, V., Prodanovic, N., Tee, M., Gutierrez-Ureña, S., Jimenez, R., Zamani, O., Lee, S., Kim, H., Park, W., & Müller-Ladner, U. (n.d.). fRI0143 A randomized, double-blind, phase 3 study demonstrates clinical equivalence of CT-P13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis. Annals of the rheumatic diseases, 71, 359. http://access.bl.uk/ark:/81055/vdc_100135180433.0x000059